Mycobacterium smegmatis MSMEG_6906 modulates IL-1β via NF-κB pathway to benefit intracellular survival
Microbial Pathogenesis · 2027-01 · 222 · 108898
DOI: 10.1016/j.micpath.2026.108898 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2027-01. Verfasst von Jiubiao Guo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Center, The First Affiliated Hospital of Shantou University Medical College, Department of Pharmacology, Shantou University Medical…. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
Tuberculosis (TB), instigated by Mycobacterium tuberculosis (Mtb), exerts a detrimental impact on public health worldwide. Mtb features unique and abundant lipids components and genes involved in lipogenesis, which are believed to provide the pathogen an advantage in the host, but the underlying mechanisms remain inconclusive. In the present study we show that Mycobacterium smegmatis (M. smegmatis) MSMEG_6906, annotated as a hydrolase that probably involved in lipid biosynthesis, functions in affecting bacterial morphology, and plays a role in modulating IL-1β expression in macrophages. The absence of MSMEG_6906 results in significantly attenuated survival of M. smegmatis in macrophages. Mechanistically, MSMEG_6906 suppresses the expression of IL-1β through nuclear factor-κB (NF-κB) signaling pathway, thus benefiting the survival of M. smegmatis in macrophages. Exogenously added IL-1β neutralizing antibody could partially rescue the bacterial load of MSMEG_6906 deficient strain to the level of wild type M. smegmatis in macrophages. Our findings broaden understanding on the interplay between mycobacterium and host immune response, provide an alternative for TB treatment or drug development in the future.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Research Center, The First Affiliated Hospital of Shantou University Medical College, Department of Pharmacology, Shantou University Medical College, Shantou, Guangdong, 515041, China; Guangdong Provincial Key…
- Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, 510440, China.
- Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Department of Pathogen Biology, School of Medicine, Shenzhen University, Shenzhen, 518060, China.
- Guangdong Provincial Key Laboratory of Medical Immunology and Molecular Diagnostics, The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, 523109, China.
- Clinical Research Center, The First Affiliated Hospital of Shantou University Medical College, Department of Pharmacology, Shantou University Medical College, Shantou, Guangdong, 515041, China.
- Laboratory of Molecular Biology, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing,…
Zitieren
APA
Guo, J., Yu, Q., Hu, Y., Huang, K., Dai, Y., Wang, Y., Dai, Z., Chen, Y., Zhu, C., & Chen, X. (2027). Mycobacterium smegmatis MSMEG_6906 modulates IL-1β via NF-κB pathway to benefit intracellular survival. Microbial Pathogenesis, 222, 108898. https://doi.org/10.1016/j.micpath.2026.108898
Vancouver
Guo J, Yu Q, Hu Y, Huang K, Dai Y, Wang Y, et al. Mycobacterium smegmatis MSMEG_6906 modulates IL-1β via NF-κB pathway to benefit intracellular survival. Microbial Pathogenesis. 2027;222:108898. doi:10.1016/j.micpath.2026.108898
BibTeX
@article{Guo2027,
author = {Guo, Jiubiao and Yu, Qing and Hu, Yunlong and Huang, Kaisong and Dai, Youchao and Wang, Yu and Dai, Zongmao and Chen, Yongru and Zhu, Chuanzhi and Chen, Xinchun},
title = {Mycobacterium smegmatis MSMEG_6906 modulates IL-1β via NF-κB pathway to benefit intracellular survival},
journal = {Microbial Pathogenesis},
year = {2027},
volume = {222},
pages = {108898},
doi = {10.1016/j.micpath.2026.108898}
}
EUVIMED